Modulation of host cell pathways by Coxiella burnetii Dot/Icm effectors

Abstract

Coxiella burnetii, the etiological agent of Q fever, is a significant intracellular bacterial pathogen. C. burnetii is a highly infectious pathogen that primarily targets pulmonary alveolar macrophages during natural infection. It can then disseminate to macrophages in other tissues and organs, leading to chronic infections. C. burnetii is capable of infecting a variety of cultured cells, including primary macrophages, macrophage-like cells, epithelial cells, and fibroblasts. The virulence of C. burnetii is entirely dependent on the Dot/Icm type IVB secretion system (T4BSS), which delivers effectors into infected cells to modulate cellular pathways for the biogenesis of the Coxiella-containing vacuole that supports its intracellular replication. A deeper understanding of how C. burnetii exploits host cell processes is essential for developing novel therapeutic strategies to combat infections caused by this important pathogen. This review summarizes the historical milestones and recent advances in our understanding of the structure and function of the C. burnetii Dot/Icm system and its effectors.

Keywords

bacterial virulence / intravacuolar pathogens / lysosome / Q fever / type IV secretion

References

[1] Maurin M, Raoult D. Q fever. Clin Microbiol Rev. 1999; 12: 518–553.

[2] Angelakis E, Raoult D. Q fever. Vet Microbiol. 2010; 140: 297–309.

[3] Maurin M, Benoliel AM, Bongrand P, Raoult D. Phagolysosomal alkalinization and the bactericidal effect of antibiotics: the Coxiella burnetii paradigm. J Infect Dis. 1992; 166: 1097–1102.

[4] Kazar J. Coxiella burnetii infection. Ann NY Acad Sci. 2005; 1063: 105–114.

[5] Eldin C, Mélenotte C, Mediannikov O, Ghigo E, Million M, Edouard S, et al. From Q fever to Coxiella burnetii infection: a paradigm change. Clin Microbiol Rev. 2017; 30: 115–190.

[6] Brooke RJ, Kretzschmar ME, Mutters NT, Teunis PF. Human dose response relation for airborne exposure to Coxiella burnetii. BMC Infect Dis. 2013; 13: 488.

[7] Madariaga MG, Rezai K, Trenholme GM, Weinstein RA. Q fever: a biological weapon in your backyard. Lancet Infect Dis. 2003; 3: 709–721.

[8] Oyston PCF, Davies C. Q fever: the neglected biothreat agent. J Med Microbiol. 2011; 60: 9–21.

[9] McCaul TF, Williams JC. Developmental cycle of Coxiella burnetii: structure and morphogenesis of vegetative and sporogenic differentiations. J Bacteriol. 1981; 147: 1063–1076.

[10] Coleman SA, Fischer ER, Howe D, Mead DJ, Heinzen RA. Temporal analysis of Coxiella burnetii morphological differentiation. J Bacteriol. 2004; 186: 7344–7352.

[11] Kumaresan V, Wang J, Zhang W, Zhang Y, Xu D, Zhang G. Coxiella burnetii virulent phase I and avirulent phase II variants differentially manipulate autophagy pathway in neutrophils. Infect Immun. 2022; 90:e0053421.

[12] Amano K, Williams JC. Chemical and immunological characterization of lipopolysaccharides from phase I and phase II Coxiella burnetii. J Bacteriol. 1984; 160: 994–1002.

[13] Hoover TA, Culp DW, Vodkin MH, Williams JC, Thompson HA. Chromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (crazy), of the Coxiella burnetii Nine Mile strain. Infect Immun. 2002; 70: 6726–6733.

[14] Amano K, Williams JC, Missler SR, Reinhold VN. Structure and biological relationships of Coxiella burnetii lipopolysaccharides. J Biol Chem. 1987; 262: 4740–4747.

[15] Assis TO, Aguiar APD, von Randow C, Nobre CA. Projections of future forest degradation and CO₂ emissions for the Brazilian Amazon. Sci Adv. 2022; 8:eabj3309.

[16] Capo C, Lindberg FP, Meconi S, Zaffran Y, Tardei G, Brown EJ, et al. Subversion of monocyte functions by Coxiella burnetii: impairment of the cross-talk between αvβ3 integrin and CR3. J Immunol. 1999; 163: 6078–6085.

[17] Howe D, Shannon JG, Winfree S, Dorward DW, Heinzen RA. Coxiella burnetii phase I and II variants replicate with similar kinetics in degradative phagolysosome-like compartments of human macrophages. Infect Immun. 2010; 78: 3465–3474.

[18] Russell-Lodrigue KE, Zhang GQ, McMurray DN, Samuel JE. Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever. Infect Immun. 2006; 74: 6085–6091.

[19] Sobotta K, Hillarius K, Mager M, Kerner K, Heydel C, Menge C. Coxiella burnetii infects primary bovine macrophages and limits their host cell response. Infect Immun. 2016; 84: 1722–1734.

[20] Martinez E, Cantet F, Fava L, Norville I, Bonazzi M. Identification of OmpA, a Coxiella burnetii protein involved in host cell invasion, by multi-phenotypic high-content screening. PLoS Pathog. 2014; 10:e1004013.

[21] Pechstein J, Schulze-Luehrmann J, Lührmann A. Coxiella burnetii as a useful tool to investigate bacteria-friendly host cell compartments. IJMM. 2018; 308: 77–83.

[22] Hackstadt T, Williams JC. Biochemical stratagem for obligate parasitism of eukaryotic cells by Coxiella burnetii. Proc Natl Acad Sci USA. 1981; 78: 3240–3244.

[23] Shepherd DC, Kaplan M, Vankadari N, Kim KW, Larson CL, Dutka P, et al. Morphological remodeling of Coxiella burnetii during its biphasic developmental cycle revealed by cryo-electron tomography. iScience. 2023; 26:107210.

[24] Costa TRD, Harb L, Khara P, Zeng L, Hu B, Christie PJ. Type IV secretion systems: advances in structure, function, and activation. Mol Microbiol. 2021; 115: 436–452.

[25] Christie PJ, Vogel JP. Bacterial type IV secretion: conjugation systems adapted to deliver effector molecules to host cells. TIM. 2000; 8: 354–360.

[26] Andrews HL, Vogel JP, Isberg RR. Identification of linked Legionella pneumophila genes essential for intracellular growth and evasion of the endocytic pathway. Infect Immun. 1998; 66: 950–958.

[27] Berger KH, Isberg RR. Two distinct defects in intracellular growth complemented by a single genetic locus in Legionella pneumophila. Mol Microbiol. 1993; 7: 7–19.

[28] Berger KH, Merriam JJ, Isberg RR. Altered intracellular targeting properties associated with mutations in the Legionella pneumophila dotA gene. Mol Microbiol. 1994; 14: 809–822.

[29] Brand BC, Sadosky AB, Shuman HA. The Legionella pneumophila icm locus: a set of genes required for intracellular multiplication in human macrophages. Mol Microbiol. 1994; 14: 797–808.

[30] Purcell M, Shuman HA. The Legionella pneumophila icmGCDJBF genes are required for killing of human macrophages. Infect Immun. 1998; 66: 2245–2255.

[31] Sadosky AB, Wiater LA, Shuman HA. Identification of Legionella pneumophila genes required for growth within and killing of human macrophages. Infect Immun. 1993; 61: 5361–5373.

[32] Segal G, Purcell M, Shuman HA. Host cell killing and bacterial conjugation require overlapping sets of genes within a 22-kb region of the Legionella pneumophila genome. Proc Natl Acad Sci USA. 1998; 95: 1669–1674.

[33] Segal G, Shuman HA. Characterization of a new region required for macrophage killing by Legionella pneumophila. Infect Immun. 1997; 65: 5057–5066.

[34] Vogel JP, Andrews HL, Wong SK, Isberg RR. Conjugative transfer by the virulence system of Legionella pneumophila. Science. 1998; 279: 873–876.

[35] Segal G, Feldman M, Zusman T. The Icm/Dot type-IV secretion systems of Legionella pneumophila and Coxiella burnetii. FEMS Microbiol Rev. 2005; 29: 65–81.

[36] Nagai H, Kubori T. Type IVB secretion systems of Legionella and other Gram-negative bacteria. Front Microbiol. 2011; 2: 136.

[37] Grohmann E, Christie PJ, Waksman G, Backert S. Type IV secretion in Gram-negative and Gram-positive bacteria. Mol Microbiol. 2018; 107: 455–471.

[38] Komano T, Yoshida T, Narahara K, Furuya N. The transfer region of IncI1 plasmid R64: similarities between R64 tra and Legionella icm/dot genes. Mol Microbiol. 2000; 35: 1348–1359.

[39] Wilkins BM, Thomas AT. DNA-independent transport of plasmid primase protein between bacteria by the I1 conjugation system. Mol Microbiol. 2000; 38: 650–657.

[40] Nagai H, Kagan JC, Zhu X, Kahn RA, Roy CR. A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes. Science. 2002; 295: 679–682.

[41] Vogel J. Turning a tiger into a house cat: using Legionella pneumophila to study Coxiella burnetii. TIM. 2004; 12: 103–105.

[42] Voth DE, Heinzen RA. Coxiella type IV secretion and cellular microbiology. Curr Opin Microbiol. 2009; 12: 74–80.

[43] Newton HJ, Kohler LJ, McDonough JA, Temoche-Diaz M, Crabill E, Hartland EL, et al. A screen of Coxiella burnetii mutants reveals important roles for Dot/Icm effectors and host autophagy in vacuole biogenesis. PLoS Pathog. 2014; 10:e1004286.

[44] Suhan M, Chen SY, Thompson HA, Hoover TA, Hill A, Williams JC. Cloning and characterization of an autonomous replication sequence from Coxiella burnetii. J Bacteriol. 1994; 176: 5233–5243.

[45] Suhan ML, Chen SY, Thompson HA. Transformation of Coxiella burnetii to ampicillin resistance. J Bacteriol. 1996; 178: 2701–2708.

[46] Beare PA, Howe D, Cockrell DC, Omsland A, Hansen B, Heinzen RA. Characterization of a Coxiella burnetii ftsZ mutant generated by Himar1 transposon mutagenesis. J Bacteriol. 2009; 191: 1369–1381.

[47] Omsland A, Beare PA, Hill J, Cockrell DC, Howe D, Hansen B, et al. Isolation from animal tissue and genetic transformation of Coxiella burnetii are facilitated by an improved axenic growth medium. Appl Environ Microbiol. 2011; 77: 3720–3725.

[48] Omsland A, Cockrell DC, Howe D, Fischer ER, Virtaneva K, Sturdevant DE, et al. Host cell-free growth of the Q fever bacterium Coxiella burnetii. Proc Natl Acad Sci USA. 2009; 106: 4430–4434.

[49] Beare PA, Gilk SD, Larson CL, Hill J, Stead CM, Omsland A, et al. Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages. mBio. 2011; 2:e00175-11.

[50] Chen C, Banga S, Mertens K, Weber MM, Gorbaslieva I, Tan Y, et al. Large-scale identification and translocation of type IV secretion substrates by Coxiella burnetii. Proc Natl Acad Sci USA. 2010; 107: 21755–21760.

[51] Beare PA, Sandoz KM, Omsland A, Rockey DD, Heinzen RA. Advances in genetic manipulation of obligate intracellular bacterial pathogens. Front Microbiol. 2011; 2: 97.

[52] Wachter S, Cockrell DC, Miller HE, Virtaneva K, Kanakabandi K, Darwitz B, et al. The endogenous Coxiella burnetii plasmid encodes a functional toxin-antitoxin system. Mol Microbiol. 2022; 118: 744–764.

[53] Steiner S, Roy CR. CRISPR-Cas9-based approaches for genetic analysis and epistatic interaction studies in Coxiella burnetii. mSphere. 2024; 9:e0052324.

[54] Carey KL, Newton HJ, Lührmann A, Roy CR. The Coxiella burnetii Dot/Icm system delivers a unique repertoire of type IV effectors into host cells and is required for intracellular replication. PLoS Pathog. 2011; 7:e1002056.

[55] Luo ZQ, Isberg RR. Multiple substrates of the Legionella pneumophila Dot/Icm system identified by interbacterial protein transfer. Proc Natl Acad Sci USA. 2004; 101: 841–846.

[56] Zusman T, Aloni G, Halperin E, Kotzer H, Degtyar E, Feldman M, et al. The response regulator PmrA is a major regulator of the icm/dot type IV secretion system in Legionella pneumophila and Coxiella burnetii. Mol Microbiol. 2007; 63: 1508–1523.

[57] Huang L, Boyd D, Amyot WM, Hempstead AD, Luo ZQ, O'Connor TJ, et al. The E block motif is associated with Legionella pneumophila translocated substrates. Cell Microbiol. 2011; 13: 227–245.

[58] Zhu W, Banga S, Tan Y, Zheng C, Stephenson R, Gately J, et al. Comprehensive identification of protein substrates of the Dot/Icm type IV transporter of Legionella pneumophila. PLoS One. 2011; 6:e17638.

[59] Weber MM, Chen C, Rowin K, Mertens K, Galvan G, Zhi H, et al. Identification of Coxiella burnetii type IV secretion substrates required for intracellular replication and Coxiella-containing vacuole formation. J Bacteriol. 2013; 195: 3914–3924.

[60] Crabill E, Schofield WB, Newton HJ, Goodman AL, Roy CR. Dot/Icm-translocated proteins important for biogenesis of the Coxiella burnetii-containing vacuole identified by screening of an effector mutant sublibrary. Infect Immun. 2018; 86:e00758-17.

[61] Qiu J, Luo ZQ. Legionella and Coxiella effectors: strength in diversity and activity. Nat Rev Microbiol. 2017; 15: 591–605.

[62] Romanov KA, O'Connor TJ. Legionella pneumophila, a Rosetta stone to understanding bacterial pathogenesis. J Bacteriol. 2024; 206:e0032424.

[63] Voth DE, Beare PA, Howe D, Sharma UM, Samoilis G, Cockrell DC, et al. The Coxiella burnetii cryptic plasmid is enriched in genes encoding type IV secretion system substrates. J Bacteriol. 2011; 193: 1493–1503.

[64] Lührmann A, Nogueira CV, Carey KL, Roy CR. Inhibition of pathogen-induced apoptosis by a Coxiella burnetii type IV effector protein. Proc Natl Acad Sci USA. 2010; 107: 18997–19001.

[65] Kohler LJ, Reed SR, Sarraf SA, Arteaga DD, Newton HJ, Roy CR. Effector protein Cig2 decreases host tolerance of infection by directing constitutive fusion of autophagosomes with the Coxiella-containing vacuole. mBio. 2016; 7:e01127-16.

[66] Martinez E, Allombert J, Cantet F, Lakhani A, Yandrapalli N, Neyret A, et al. Coxiella burnetii effector CvpB modulates phosphoinositide metabolism for optimal vacuole development. Proc Natl Acad Sci USA. 2016; 113: E3260–E3269.

[67] Weber MM, Faris R, van Schaik EJ, McLachlan JT, Wright WU, Tellez A, et al. The type IV secretion system effector protein CirA stimulates the GTPase activity of RhoA and is required for virulence in a mouse model of Coxiella burnetii infection. Infect Immun. 2016; 84: 2524–2533.

[68] Lifshitz Z, Burstein D, Schwartz K, Shuman HA, Pupko T, Segal G. Identification of novel Coxiella burnetii Icm/Dot effectors and genetic analysis of their involvement in modulating a mitogen-activated protein kinase pathway. Infect Immun. 2014; 82: 3740–3752.

[69] Fielden LF, Moffatt JH, Kang Y, Baker MJ, Khoo CA, Roy CR, et al. A farnesylated Coxiella burnetii effector forms a multimeric complex at the mitochondrial outer membrane during infection. Infect Immun. 2017; 85:e01046-16.

[70] Burette M, Allombert J, Lambou K, Maarifi G, Nisole S, Di Russo Case E, et al. Modulation of innate immune signaling by a Coxiella burnetii eukaryotic-like effector protein. Proc Natl Acad Sci USA. 2020; 117: 13708–13718.

[71] Rodríguez-Escudero M, Cid VJ, Molina M, Schulze-Luehrmann J, Lührmann A, Rodríguez-Escudero I. Studying Coxiella burnetii type IV substrates in the yeast Saccharomyces cerevisiae: focus on subcellular localization and protein aggregation. PLoS One. 2016; 11:e0148032.

[72] Martinez E, Huc-Brandt S, Brelle S, Allombert J, Cantet F, Gannoun-Zaki L, et al. The secreted protein kinase CstK from Coxiella burnetii influences vacuole development and interacts with the GTPase-activating host protein TBC1D5. J Biol Chem. 2020; 295: 7391–7403.

[73] Fu M, Liu Y, Wang G, Wang P, Zhang J, Chen C, et al. A protein-protein interaction map reveals that the Coxiella burnetii effector CirB inhibits host proteasome activity. PLoS Pathog. 2022; 18:e1010660.

[74] Pechstein J, Schulze-Luehrmann J, Bisle S, Cantet F, Beare PA, Ölke M, et al. The Coxiella burnetii T4SS effector AnkF is important for intracellular replication. Front Cell Infect Microbiol. 2020; 10:559915.

[75] Zhang Y, Fu J, Liu S, Wang L, Qiu J, van Schaik EJ, et al. Coxiella burnetii inhibits host immunity by a protein phosphatase adapted from glycolysis. Proc Natl Acad Sci USA. 2022; 119:e2110877119.

[76] Siadous FA, Cantet F, Van Schaik E, Burette M, Allombert J, Lakhani A, et al. Coxiella effector protein CvpF subverts RAB26-dependent autophagy to promote vacuole biogenesis and virulence. Autophagy. 2021; 17: 706–722.

[77] Larson CL, Beare PA, Howe D, Heinzen RA. Coxiella burnetii effector protein subverts clathrin-mediated vesicular trafficking for pathogen vacuole biogenesis. Proc Natl Acad Sci USA. 2013; 110: E4770–E4779.

[78] Höpfner D, Cichy A, Pogenberg V, Krisp C, Mezouar S, Bach NC, et al. The DNA-binding induced (de)AMPylation activity of a Coxiella burnetii Fic enzyme targets Histone H3. Commun Biol. 2023; 6: 1124.

[79] Fielden LF, Scott NE, Palmer CS, Khoo CA, Newton HJ, Stojanovski D. Proteomic identification of Coxiella burnetii effector proteins targeted to the host cell mitochondria during infection. Mol Cell Proteomics. 2021; 20:100005.

[80] Yang Z, Duncan-Lowey JK, Roy CR. Identification of a Coxiella burnetii outer membrane porin required for intracellular replication. Infect Immun. 2025; 93:e0044824.

[81] Duncan-Lowey J, Crabill E, Jarret A, Reed SCO, Roy CR. The Coxiella burnetii effector EmcB is a deubiquitinase that inhibits RIG-I signaling. Proc Natl Acad Sci USA. 2023; 120:e2217602120.

[82] Angara RK, Sadi A, Gilk SD. A novel bacterial effector protein mediates ER-LD membrane contacts to regulate host lipid droplets. EMBO Rep. 2024; 25: 5331–5351.

[83] Ende RJ, Derré I. Making contact away from home: a bacterial secreted effector mediates inter-organelle communication. EMBO Rep. 2024; 25: 5236–5238.

[84] Klingenbeck L, Eckart RA, Berens C, Lührmann A. The Coxiella burnetii type IV secretion system substrate CaeB inhibits intrinsic apoptosis at the mitochondrial level. Cell Microbiol. 2013; 15: 675–687.

[85] Bisle S, Klingenbeck L, Borges V, Sobotta K, Schulze-Luehrmann J, Menge C, et al. The inhibition of the apoptosis pathway by the Coxiella burnetii effector protein CaeA requires the EK repetition motif, but is independent of survivin. Virulence. 2016; 7: 400–412.

[86] Loterio RK, Thomas DR, Andrade W, Lee YW, Santos LL, Mascarenhas DPA, et al. Coxiella co-opts the glutathione peroxidase 4 to protect the host cell from oxidative stress-induced cell death. Proc Natl Acad Sci USA. 2023; 120:e2308752120.

[87] Larson CL, Beare PA, Voth DE, Howe D, Cockrell DC, Bastidas RJ, et al. Coxiella burnetii effector proteins that localize to the parasitophorous vacuole membrane promote intracellular replication. Infect Immun. 2015; 83: 661–670.

[88] Latomanski EA, Newton P, Khoo CA, Newton HJ. The effector Cig57 hijacks FCHO-mediated vesicular trafficking to facilitate intracellular replication of Coxiella burnetii. PLoS Pathog. 2016; 12:e1006101.

[89] Cunha LD, Ribeiro JM, Fernandes TD, Massis LM, Khoo CA, Moffatt JH, et al. Inhibition of inflammasome activation by Coxiella burnetii type IV secretion system effector IcaA. Nat Commun. 2015; 6:10205.

[90] Larson CL, Pullman W, Beare PA, Heinzen RA. Identification of type 4B secretion system substrates that are conserved among Coxiella burnetii genomes and promote intracellular growth. Microbiol Spectr. 2023; 11:e0069623.

[91] Zhao M, Zhang S, Wan W, Zhou C, Li N, Cheng R, et al. Coxiella burnetii effector CvpE maintains biogenesis of Coxiella-containing vacuoles by suppressing lysosome tubulation through binding PI(3)P and perturbing PIKfyve activity on lysosomes. Virulence. 2024; 15:2350893.

[92] Kuba M, Neha N, Newton P, Lee YW, Bennett-Wood V, Hachani A, et al. EirA is a novel protein essential for intracellular replication of Coxiella burnetii. Infect Immun. 2020; 88: e00913–e00919.

[93] Kaksonen M, Roux A. Mechanisms of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol. 2018; 19: 313–326.

[94] Cocucci E, Aguet F, Boulant S, Kirchhausen T. The first five seconds in the life of a clathrin-coated pit. Cell. 2012; 150: 495–507.

[95] Peng Y, Grassart A, Lu R, Wong CCL, Yates J, Barnes G, et al. Casein kinase 1 promotes initiation of clathrin-mediated endocytosis. Dev Cell. 2015; 32: 231–240.

[96] Traub LM. Tickets to ride: selecting cargo for clathrin-regulated internalization. Nat Rev Mol Cell Biol. 2009; 10: 583–596.

[97] Liu AP, Aguet F, Danuser G, Schmid SL. Local clustering of transferrin receptors promotes clathrin-coated pit initiation. J Cell Biol. 2010; 191: 1381–1393.

[98] Traub LM. Regarding the amazing choreography of clathrin coats. PLoS Biol. 2011; 9:e1001037.

[99] Kadlecova Z, Spielman SJ, Loerke D, Mohanakrishnan A, Reed DK, Schmid SL. Regulation of clathrin-mediated endocytosis by hierarchical allosteric activation of AP2. J Cell Biol. 2017; 216: 167–179.

[100] Maxfield FR, McGraw TE. Endocytic recycling. Nat Rev Mol Cell Biol. 2004; 5: 121–132.

[101] Hopkins CR. Intracellular routing of transferrin and transferrin receptors in epidermoid carcinoma A431 cells. Cell. 1983; 35: 321–330.

[102] Yamashiro DJ, Tycko B, Fluss SR, Maxfield FR. Segregation of transferrin to a mildly acidic (pH 6.5) para-Golgi compartment in the recycling pathway. Cell. 1984; 37: 789–800.

[103] McGraw TE, Dunn KW, Maxfield FR. Isolation of a temperature-sensitive variant Chinese hamster ovary cell line with a morphologically altered endocytic recycling compartment. J Cell Physiol. 1993; 155: 579–594.

[104] Newton P, Latomanski EA, Newton HJ. Applying fluorescence resonance energy transfer (FRET) to examine effector translocation efficiency by Coxiella burnetii during siRNA silencing. J Vis Exp. 2016; 113:54210.

[105] Beare PA, Unsworth N, Andoh M, Voth DE, Omsland A, Gilk SD, et al. Comparative genomics reveal extensive transposon-mediated genomic plasticity and diversity among potential effector proteins within the genus Coxiella. Infect Immun. 2009; 77: 642–656.

[106] Ullrich O, Reinsch S, Urbé S, Zerial M, Parton RG. Rab11 regulates recycling through the pericentriolar recycling endosome. J Cell Biol. 1996; 135: 913–924.

[107] Ren M, Xu G, Zeng J, De Lemos-Chiarandini C, Adesnik M, Sabatini DD. Hydrolysis of GTP on rab11 is required for the direct delivery of transferrin from the pericentriolar recycling compartment to the cell surface but not from sorting endosomes. Proc Natl Acad Sci USA. 1998; 95: 6187–6192.

[108] Wilcke M, Johannes L, Galli T, Mayau V, Goud B, Salamero J. Rab11 regulates the compartmentalization of early endosomes required for efficient transport from early endosomes to the trans-Golgi network. J Cell Biol. 2000; 151: 1207–1220.

[109] Keyel PA, Mishra SK, Roth R, Heuser JE, Watkins SC, Traub LM. A single common portal for clathrin-mediated endocytosis of distinct cargo governed by cargo-selective adaptors. Mol Biol Cell. 2006; 17: 4300–4317.

[110] Motley A, Bright NA, Seaman MNJ, Robinson MS. Clathrin-mediated endocytosis in AP-2-depleted cells. J Cell Biol. 2003; 162: 909–918.

[111] Lippincott-Schwartz J, Yuan L, Tipper C, Amherdt M, Orci L, Klausner RD. Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell. 1991; 67: 601–616.

[112] Uezu A, Umeda K, Tsujita K, Suetsugu S, Takenawa T, Nakanishi H. Characterization of the EFC/F-BAR domain protein, FCHO2. Genes Cells. 2011; 16: 868–878.

[113] Henne WM, Kent HM, Ford MGJ, Hegde BG, Daumke O, Butler PJG, et al. Structure and analysis of FCHo2 F-BAR domain: a dimerizing and membrane recruitment module that effects membrane curvature. Structure. 2007; 15: 839–852.

[114] Henne WM, Boucrot E, Meinecke M, Evergren E, Vallis Y, Mittal R, et al. FCHo proteins are nucleators of clathrin-mediated endocytosis. Science. 2010; 328: 1281–1284.

[115] Schoenlaub L, Cherla R, Zhang Y, Zhang G. Coxiella burnetii avirulent Nine Mile phase II induces Caspase-1-dependent pyroptosis in murine peritoneal B1a B cells. Infect Immun. 2016; 84: 3638–3654.

[116] Birmingham CL, Smith AC, Bakowski MA, Yoshimori T, Brumell JH. Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J Biol Chem. 2006; 281: 11374–11383.

[117] Nakagawa I, Amano A, Mizushima N, Yamamoto A, Yamaguchi H, Kamimoto T, et al. Autophagy defends cells against invading group A Streptococcus. Science. 2004; 306: 1037–1040.

[118] Kimmey JM, Stallings CL. Bacterial pathogens versus autophagy: implications for therapeutic interventions. Trends Mol Med. 2016; 22: 1060–1076.

[119] Bhogaraju S, Kalayil S, Liu Y, Bonn F, Colby T, Matic I, et al. Phosphoribosylation of ubiquitin promotes serine ubiquitination and impairs conventional ubiquitination. Cell. 2016; 167: 1636–1649.

[120] Qiu J, Sheedlo MJ, Yu K, Tan Y, Nakayasu ES, Das C, et al. Ubiquitination independent of E1 and E2 enzymes by bacterial effectors. Nature. 2016; 533: 120–124.

[121] Romano PS, Gutierrez MG, Berón W, Rabinovitch M, Colombo MI. The autophagic pathway is actively modulated by phase II Coxiella burnetii to efficiently replicate in the host cell. Cell Microbiol. 2007; 9: 891–909.

[122] Winchell CG, Graham JG, Kurten RC, Voth DE. Coxiella burnetii type IV secretion-dependent recruitment of macrophage autophagosomes. Infect Immun. 2014; 82: 2229–2238.

[123] McDonough JA, Newton HJ, Klum S, Swiss R, Agaisse H, Roy CR. Host pathways important for Coxiella burnetii infection revealed by genome-wide RNA interference screening. mBio. 2013; 4:e00606-12.

[124] Bird LE, Xu B, Hobbs AD, Ziegler AR, Scott NE, Newton P, et al. Coxiella burnetii manipulates the lysosomal protease cathepsin B to facilitate intracellular success. Nat Commun. 2025; 16: 3844.

[125] Donaldson JG, Finazzi D, Klausner RD. Brefeldin A inhibits Golgi membrane-catalysed exchange of guanine nucleotide onto ARF protein. Nature. 1992; 360: 350–352.

[126] Helms JB, Rothman JE. Inhibition by brefeldin A of a Golgi membrane enzyme that catalyses exchange of guanine nucleotide bound to ARF. Nature. 1992; 360: 352–354.

[127] Dong W, He B, Qian H, Liu Q, Wang D, Li J, et al. RAB26-dependent autophagy protects adherens junctional integrity in acute lung injury. Autophagy. 2018; 14: 1677–1692.

[128] Fu M, Zhang J, Zhao M, Zhang S, Dai L, Ouyang X, et al. Coxiella burnetii plasmid effector B promotes LC3-II accumulation and contributes to bacterial virulence in a SCID mouse model. Infect Immun. 2022; 90:e0001622.

[129] Puri C, Vicinanza M, Ashkenazi A, Gratian MJ, Zhang Q, Bento CF, et al. The RAB11A-positive compartment is a primary platform for autophagosome assembly mediated by WIPI2 recognition of PI3P-RAB11A. Dev Cell. 2018; 45: 114–131.

[130] Campoy E, Zoppino FC, Colombo I. The early secretory pathway contributes to the growth of the Coxiella-replicative niche. Infect Immun. 2011; 79: 402–413.

[131] Berón W, Gutierrez MG, Rabinovitch M, Colombo MI. Coxiella burnetii localizes in a Rab7-labeled compartment with autophagic characteristics. Infect Immun. 2002; 70: 5816–5821.

[132] Gutierrez MG, Vázquez CL, Munafó DB, Zoppino FCM, Berón W, Rabinovitch M, et al. Autophagy induction favours the generation and maturation of the Coxiella-replicative vacuoles. Cell Microbiol. 2005; 7: 981–993.

[133] Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998; 281: 1312–1316.

[134] Lamkanfi M, Dixit VM. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe. 2010; 8: 44–54.

[135] Häcker G. Apoptosis in infection. Microb Infect. 2018; 20: 552–559.

[136] Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med. 1999; 5: 1249–1255.

[137] Saelens X, Festjens N, Walle LV, Gurp M, Loo G, Vandenabeele P. Toxic proteins released from mitochondria in cell death. Oncogene. 2004; 23: 2861–2874.

[138] Cain K, Bratton SB, Cohen GM. The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie. 2002; 84: 203–214.

[139] Fischer U, Jänicke RU, Schulze-Osthoff K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 2003; 10: 76–100.

[140] Taylor RC, Cullen SP, Martin SJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol. 2008; 9: 231–241.

[141] Timmer JC, Salvesen GS. Caspase substrates. Cell Death Differ. 2007; 14: 66–72.

[142] Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 1993; 75: 1169–1178.

[143] Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem. 1995; 270: 7795–7798.

[144] Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 1995; 14: 5579–5588.

[145] Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther. 2005; 4: 147–171.

[146] Strasser A, Jost PJ, Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity. 2009; 30: 180–192.

[147] Li H, Zhu H, Xu C, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998; 94: 491–501.

[148] Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998; 94: 481–490.

[149] Nogueira CV, Lindsten T, Jamieson AM, Case CL, Shin S, Thompson CB, et al. Rapid pathogen-induced apoptosis: a mechanism used by dendritic cells to limit intracellular replication of Legionella pneumophila. PLoS Pathog. 2009; 5:e1000478.

[150] Marriott HM, Bingle CD, Read RC, Braley KE, Kroemer G, Hellewell PG, et al. Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance. J Clin Invest. 2005; 115: 359–368.

[151] Cummins NW, Badley AD. Mechanisms of HIV-associated lymphocyte apoptosis: 2010. Cell Death Dis. 2010; 1:e99.

[152] Selliah N, Finkel TH. Biochemical mechanisms of HIV induced T cell apoptosis. Cell Death Differ. 2001; 8: 127–136.

[153] Hotchkiss RS, Osmon SB, Chang KC, Wagner TH, Coopersmith CM, Karl IE. Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol. 2005; 174: 5110–5118.

[154] Le Tulzo Y, Pangault C, Gacouin A, Guilloux V, Tribut O, Amiot L, et al. Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock. 2002; 18: 487–494.

[155] Eckart RA, Bisle S, Schulze-Luehrmann J, Wittmann I, Jantsch J, Schmid B, et al. Antiapoptotic activity of Coxiella burnetii effector protein AnkG is controlled by p32-dependent trafficking. Infect Immun. 2014; 82: 2763–2771.

[156] Schäfer W, Eckart RA, Schmid B, Cagköylü H, Hof K, Muller YA, et al. Nuclear trafficking of the anti-apoptotic Coxiella burnetii effector protein AnkG requires binding to p32 and Importin-α1. Cell Microbiol. 2017; 19:e12634.

[157] Cordsmeier A, Rinkel S, Jeninga M, Schulze-Luehrmann J, Ölke M, Schmid B, et al. The Coxiella burnetii T4SS effector protein AnkG hijacks the 7SK small nuclear ribonucleoprotein complex for reprogramming host cell transcription. PLoS Pathog. 2022; 18:e1010266.

[158] Cordsmeier A, Wagner N, Lührmann A, Berens C. Defying death—how Coxiella burnetii copes with intentional host cell suicide. Yale J Biol Med. 2019; 92: 619–628.

[159] Schulze-Luehrmann J, Liebler-Tenorio E, Felipe-López A, Lührmann A. Cell death induction facilitates egress of Coxiella burnetii from infected host cells at late stages of infection. Mol Microbiol. 2024; 121: 513–528.

[160] Chauhan M, Osbron CA, Koehler HS, Goodman AG. STING dependent BAX-IRF3 signaling results in apoptosis during late-stage Coxiella burnetii infection. Cell Death Dis. 2024; 15: 195.

[161] Ablasser A, Chen ZJ. cGAS in action: expanding roles in immunity and inflammation. Science. 2019; 363:eaat8657.

[162] Man SM, Karki R, Kanneganti TD. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev. 2017; 277: 61–75.

[163] Ding J, Wang K, Liu W, She Y, Sun Q, Shi J, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016; 535: 111–116.

[164] Aglietti RA, Estevez A, Gupta A, Ramirez MG, Liu PS, Kayagaki N, et al. GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc Natl Acad Sci USA. 2016; 113: 7858–7863.

[165] Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016; 535: 153–158.

[166] Sborgi L, Rühl S, Mulvihill E, Pipercevic J, Heilig R, Stahlberg H, et al. GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death. EMBO J. 2016; 35: 1766–1778.

[167] Shi X, Sun Q, Hou Y, Zeng H, Cao Y, Dong M, et al. Recognition and maturation of IL-18 by caspase-4 noncanonical inflammasome. Nature. 2023; 624: 442–450.

[168] Hotta A, Kawamura M, To H, Andoh M, Yamaguchi T, Fukushi H, et al. Phase variation analysis of Coxiella burnetii during serial passage in cell culture by use of monoclonal antibodies. Infect Immun. 2002; 70: 4747–4749.

[169] Case CL, Kohler LJ, Lima JB, Strowig T, de Zoete MR, Flavell RA, et al. Caspase-11 stimulates rapid flagellin-independent pyroptosis in response to Legionella pneumophila. Proc Natl Acad Sci USA. 2013; 110: 1851–1856.

[170] Hagar JA, Powell DA, Aachoui Y, Ernst RK, Miao EA. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science. 2013; 341: 1250–1253.

[171] Hayden MS, Ghosh S. NF-κB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012; 26: 203–234.

[172] Rahman MM, McFadden G. Modulation of NF-κB signalling by microbial pathogens. Nat Rev Microbiol. 2011; 9: 291–306.

[173] Asrat S, Davis KM, Isberg RR. Modulation of the host innate immune and inflammatory response by translocated bacterial proteins. Cell Microbiol. 2015; 17: 785–795.

[174] Mahapatra S, Gallaher B, Smith SC, Graham JG, Voth DE, Shaw EI. Coxiella burnetii employs the Dot/Icm type IV secretion system to modulate host NF-κB/RelA activation. Front Cell Infect Microbiol. 2016; 6: 188.

[175] Larson CL, Martinez E, Beare PA, Jeffrey B, Heinzen RA, Bonazzi M. Right on Q: genetics begin to unravel Coxiella burnetii host cell interactions. Future Microbiol. 2016; 11: 919–939.

[176] Buck MD, Sowell RT, Kaech SM, Pearce EL. Metabolic instruction of immunity. Cell. 2017; 169: 570–586.

[177] Zhu W, Chu H, Zhang Y, Luo T, Yu H, Zhu H, et al. Fructose-1,6-bisphosphatase 1 dephosphorylates IκBα and suppresses colorectal tumorigenesis. Cell Res. 2023; 33: 245–257.

[178] Case EDR, Mahapatra S, Hoffpauir CT, Konganti K, Hillhouse AE, Samuel JE, et al. Primary murine macrophages as a tool for virulence factor discovery in Coxiella burnetii. Microbiol Spectr. 2022; 10:e0248421.

[179] Boxx GM, Cheng G. The roles of type I interferon in bacterial infection. Cell Host Microbe. 2016; 19: 760–769.

[180] Opitz B, Vinzing M, van Laak V, Schmeck B, Heine G, Günther S, et al. Legionella pneumophila induces IFNβ in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication. J Biol Chem. 2006; 281: 36173–36179.

[181] Monroe KM, McWhirter SM, Vance RE. Identification of host cytosolic sensors and bacterial factors regulating the type I interferon response to Legionella pneumophila. PLoS Pathog. 2009; 5:e1000665.

[182] Chiu YH, Macmillan JB, Chen ZJ. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell. 2009; 138: 576–591.

[183] Lippmann J, Müller HC, Naujoks J, Tabeling C, Shin S, Witzenrath M, et al. Dissection of a type I interferon pathway in controlling bacterial intracellular infection in mice. Cell Microbiol. 2011; 13: 1668–1682.

[184] Watson RO, Bell SL, MacDuff DA, Kimmey JM, Diner EJ, Olivas J, et al. The cytosolic sensor cGAS detects Mycobacterium tuberculosis DNA to induce type I interferons and activate autophagy. Cell Host Microbe. 2015; 17: 811–819.

[185] Bradley WP, Boyer MA, Nguyen HT, Birdwell LD, Yu J, Ribeiro JM, et al. Primary role for Toll-like receptor-driven tumor necrosis factor rather than cytosolic immune detection in restricting Coxiella burnetii phase II replication within mouse macrophages. Infect Immun. 2016; 84: 998–1015.

[186] Clemente TM, Mulye M, Justis AV, Nallandhighal S, Tran TM, Gilk SD. Coxiella burnetii blocks intracellular interleukin-17 signaling in macrophages. Infect Immun. 2018; 86:e00532-18.

[187] Stüven E, Porat A, Shimron F, Fass E, Kaloyanova D, Brügger B, et al. Intra-Golgi protein transport depends on a cholesterol balance in the lipid membrane. J Biol Chem. 2003; 278: 53112–53122.

[188] van der Kant R, Fish A, Janssen L, Janssen H, Krom S, Ho N, et al. Late endosomal transport and tethering are coupled processes controlled by RILP and the cholesterol sensor ORP1L. J Cell Sci. 2013; 126: 3462–3474.

[189] Eden ER, Sanchez-Heras E, Tsapara A, Sobota A, Levine TP, Futter CE. Annexin A1 tethers membrane contact sites that mediate ER to endosome cholesterol transport. Dev Cell. 2016; 37: 473–483.

[190] Gilk SD, Cockrell DC, Luterbach C, Hansen B, Knodler LA, Ibarra JA, et al. Bacterial colonization of host cells in the absence of cholesterol. PLoS Pathog. 2013; 9:e1003107.

[191] Mulye M, Samanta D, Winfree S, Heinzen RA, Gilk SD. Elevated cholesterol in the Coxiella burnetii intracellular niche is bacteriolytic. mBio. 2017; 8:e02313-16.

[192] Liscum L, Faust JR. The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-β-[2-(diethylamino)ethoxy]androst-5-en-17-one. J Biol Chem. 1989; 264: 11796–11806.

[193] Howe D, Heinzen RA. Coxiella burnetii inhabits a cholesterol-rich vacuole and influences cellular cholesterol metabolism. Cell Microbiol. 2006; 8: 496–507.

[194] Hayek I, Berens C, Lührmann A. Modulation of host cell metabolism by T4SS-encoding intracellular pathogens. Curr Opin Microbiol. 2019; 47: 59–65.

[195] Justis AV, Hansen B, Beare PA, King KB, Heinzen RA, Gilk SD. Interactions between the Coxiella burnetii parasitophorous vacuole and the endoplasmic reticulum involve the host protein ORP1L. Cell Microbiol. 2017; 19:e12637.

[196] Boutry M, Kim PK. ORP1L mediated PI(4)P signaling At ER-lysosome-mitochondrion three-way contact contributes to mitochondrial division. Nat Commun. 2021; 12: 5354.

[197] Mulye M, Zapata B, Gilk SD. Altering lipid droplet homeostasis affects Coxiella burnetii intracellular growth. PLoS One. 2018; 13:e0192215.

[198] Sandoz KM, Beare PA, Cockrell DC, Heinzen RA. Complementation of arginine auxotrophy for genetic transformation of Coxiella burnetii by use of a defined axenic medium. Appl Environ Microbiol. 2016; 82: 3042–3051.

[199] Häuslein I, Cantet F, Reschke S, Chen F, Bonazzi M, Eisenreich W. Multiple substrate usage of Coxiella burnetii to feed a bipartite metabolic network. Front Cell Infect Microbiol. 2017; 7: 285.

[200] Hackstadt T, Williams JC. Stability of the adenosine 5′-triphosphate pool in Coxiella burnetii: influence of pH and substrate. J Bacteriol. 1981; 148: 419–425.

[201] Seshadri R, Paulsen IT, Eisen JA, Read TD, Nelson KE, Nelson WC, et al. Complete genome sequence of the Q-fever pathogen Coxiella burnetii. Proc Natl Acad Sci USA. 2003; 100: 5455–5460.

[202] Stewart M. Molecular mechanism of the nuclear protein import cycle. Nat Rev Mol Cell Biol. 2007; 8: 195–208.

[203] Anand I, Choi W, Isberg RR. The vacuole guard hypothesis: how intravacuolar pathogens fight to maintain the integrity of their beloved home. Curr Opin Microbiol. 2020; 54: 51–58.

[204] Milione RR, Schell BB, Douglas CJ, Seath CP. Creative approaches using proximity labeling to gain new biological insights. Trends Biochem Sci. 2024; 49: 224–235.

[205] Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024; 630: 493–500.

RIGHTS & PERMISSIONS

2025 The Author(s). mLife published by John Wiley & Sons Australia, Ltd on behalf of Institute of Microbiology, Chinese Academy of Sciences.